United States · FDA National Drug Code directory

Spironolactone

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43063-832_525ac2f1-7053-88ff-e063-6294a90adcb6
Product NDC: 43063-832
Form: TABLET, FILM COATED
Composition / generic term: spironolactone
Labeler: PD-Rx Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20170602
Source listing expiry: 20271231

Source-listed ingredients

SPIRONOLACTONE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-832-01) · 43063-832-01
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-832-30) · 43063-832-30
60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-832-60) · 43063-832-60
90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-832-90) · 43063-832-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →